影像组学分析增强CT在结直肠癌患者肝脏局灶性病变分类中的价值:与放射科医师相比的局限性
该回顾性研究纳入502例结直肠癌患者,基于门静脉期腹部CT开发影像组学模型鉴别肝囊肿、血管瘤和转移瘤,并与4名放射科医师比较。模型总体及血管瘤、转移瘤特异性多分类判别指数均显著低于医师,鉴别转移瘤与良性病变的准确率为84.36%、AUC为0.9426。模型对血管瘤和亚厘米病变分类局限性明显。
要点
- 影像组学模型在门静脉期CT上鉴别结直肠癌肝转移与良性病变效能优秀,AUC达0.9426。
- 模型鉴别肝血管瘤及亚厘米病变能力有限,PDI分别为0.6653和0.6486。
- 放射科医师整体诊断效能显著优于影像组学模型,阅片仍为核心。
核心结论
- 影像组学模型虽劣于放射科医师,但在结直肠癌患者门静脉期CT上鉴别肝囊肿、血管瘤与转移瘤仍具有较好诊断效能。
- 模型局限性主要体现在血管瘤分类和亚厘米病变的分类上。
研究设计与样本
- 训练队列386例,验证队列116例,基于门静脉期腹部CT图像开发三分类影像组学模型。
- 采用ReliefF方法进行特征选择,随机森林分类器训练模型,并与4名放射科医师的诊断效能比较。
- 根据病变大小进行亚组分析。
诊断标准与关键数值
- 影像组学模型总体多分类判别指数(PDI)为0.8037,血管瘤特异性PDI为0.6653,转移瘤特异性PDI为0.8027。
- 放射科医师总体PDI为0.9622-0.9680,血管瘤特异性PDI为0.9452-0.9630,转移瘤特异性PDI为0.9511-0.9869。
- 亚组分析中,模型PDI在病变<10 mm时为0.6486,≥10 mm时为0.8264;医师PDI相对稳定。
- 模型鉴别转移瘤与良性病变的准确率为84.36%,AUC为0.9426。
临床应用与阅片要点
- 门静脉期CT影像组学模型可作为辅助工具鉴别结直肠癌肝转移与良性病变,尤其适用于≥10 mm病变。
- 对血管瘤和亚厘米病变,模型判别能力有限,需结合放射科医师阅片避免误诊。
局限性
- 研究为回顾性设计,证据等级受限。
- 模型对血管瘤和亚厘米病变分类效能不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate diagnostic performance of a radiomics model for classifying hepatic cyst, hemangioma, and metastasis in patients with colorectal cancer (CRC) from portal-phase abdominopelvic CT images.
METHODS: This retrospective study included 502 CRC patients who underwent contrast-enhanced CT and contrast-enhanced liver MRI between January 2005 and December 2010. Portal-phase CT images of training (n = 386) and validation (n = 116) cohorts were used to develop a radiomics model for differentiating three classes of liver lesions. Among multiple handcrafted features, the feature selection was performed using ReliefF method, and random forest classifiers were used to train the selected features. Diagnostic performance of the developed model was compared with that of four radiologists. A subgroup analysis was conducted based on lesion size.
RESULTS: The radiomics model demonstrated significantly lower overall and hemangioma- and metastasis-specific polytomous discrimination index (PDI) (overall, 0.8037; hemangioma-specific, 0.6653; metastasis-specific, 0.8027) than the radiologists (overall, 0.9622-0.9680; hemangioma-specific, 0.9452-0.9630; metastasis-specific, 0.9511-0.9869). For subgroup analysis, the PDI of the radiomics model was different according to the lesion size (< 10 mm, 0.6486; ≥ 10 mm, 0.8264) while that of the radiologists was relatively maintained. For classifying metastasis from benign lesions, the radiomics model showed excellent diagnostic performance, with an accuracy of 84.36% and an AUC of 0.9426.
CONCLUSION: Albeit inferior to the radiologists, the radiomics model achieved substantial diagnostic performance when differentiating hepatic lesions from portal-phase CT images of CRC patients. This model was limited particularly to classifying hemangiomas and subcentimeter lesions.
KEY POINTS: • Albeit inferior to the radiologists, the radiomics model could differentiate cyst, hemangioma, and metastasis with substantial diagnostic performance using portal-phase CT images of colorectal cancer patients. • The radiomics model demonstrated limitations especially in classifying hemangiomas and subcentimeter liver lesions.
引用
- Bae H, Lee H, Kim S, et al. Radiomics analysis of contrast-enhanced CT for classification of hepatic focal lesions in colorectal cancer patients: its limitations compared to radiologists. Eur Radiol. 2021. PMID: 33970307. doi:10.1007/s00330-021-07877-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。